SMARCA4 loss irrelevant for ARID1A mutated ovarian clear cell carcinoma: A case report
Clear cell carcinomas are rare and relatively chemo-insensitive ovarian cancers with a characteristic molecular pathogenesis. Alterations in ARID1A, a component of the multiprotein chromatin remodeling complex SWI/SNF, are likely early events in the development of ovarian clear cancers arising from...
Saved in:
Main Authors: | Samantha Kay Wagner (Author), Ashley S. Moon (Author), Brooke E. Howitt (Author), Malte Renz (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
by: Halide Nur URER, et al.
Published: (2023) -
Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
by: Huijuan Ge, et al.
Published: (2021) -
Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review
by: Huanli Duan, et al.
Published: (2021) -
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
by: Yu-Chien Lin, et al.
Published: (2020) -
SMARCA4 germline gene mutation in a patient with epithelial ovarian: A case report
by: Reshma Muppala, et al.
Published: (2017)